These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 31544294

  • 1. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M, Zhang Q, Tian XH, Wang JL, Niu YX, Li G.
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [Abstract] [Full Text] [Related]

  • 2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B.
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [Abstract] [Full Text] [Related]

  • 3. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY, Li N, Cui YL.
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [Abstract] [Full Text] [Related]

  • 4. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X, Li H, Shi J.
    Biomed Res Int; 2019 Jul; 2019():8645153. PubMed ID: 31275988
    [Abstract] [Full Text] [Related]

  • 5. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 6. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 7. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD, Wang ZL.
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH, Ma ZH, Wang X.
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [Abstract] [Full Text] [Related]

  • 9. LncRNA TUG1 promotes esophageal cancer development through regulating PLK1 expression by sponging miR-1294.
    Zong M, Feng W, Wan L, Yu X, Yu W.
    Biotechnol Lett; 2020 Dec; 42(12):2537-2549. PubMed ID: 33009634
    [Abstract] [Full Text] [Related]

  • 10. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
    Xiao ZS, Zhao L, Zhang XN, Li HX, Yin ZH.
    J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
    [Abstract] [Full Text] [Related]

  • 11. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW, Jia YX, Zhang WJ, Song LJ, Gao M, Li MJ, Zhao RH, Li J, Zhong YL, Sun QZ, Qin YR.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):56. PubMed ID: 29530057
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH, Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ, Wang K.
    Aging (Albany NY); 2021 Jun 03; 13(13):17155-17176. PubMed ID: 34081626
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y, Lu Y.
    FASEB J; 2020 May 03; 34(5):6055-6069. PubMed ID: 32239565
    [Abstract] [Full Text] [Related]

  • 14. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T, Li R, Zhao H, Deng J, Long Y, Shuai MT, Li Q, Gu H, Chen YQ, Leng AM.
    Oncotarget; 2016 Oct 11; 7(41):66851-66864. PubMed ID: 27588477
    [Abstract] [Full Text] [Related]

  • 15. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK, Wong OG, Wong ES, Chan KK, Ip PP, Tse KY, Cheung AN.
    Int J Cancer; 2018 Sep 15; 143(6):1456-1469. PubMed ID: 29663364
    [Abstract] [Full Text] [Related]

  • 16. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
    Li Y, Zhu G, Ma Y, Qu H.
    J Cell Biochem; 2019 Dec 15; 120(12):19457-19468. PubMed ID: 31478245
    [Abstract] [Full Text] [Related]

  • 17. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.
    Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, Shu Y, Chen J.
    Nucleic Acids Res; 2017 Apr 07; 45(6):3086-3101. PubMed ID: 27956498
    [Abstract] [Full Text] [Related]

  • 18. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
    Chen Z, Lin J, Wu S, Xu C, Chen F, Huang Z.
    Exp Cell Res; 2018 Jan 01; 362(1):90-101. PubMed ID: 29126868
    [Abstract] [Full Text] [Related]

  • 19. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J, Liu G, Li R, Xiao P, Yang D, Bai H, Hao Y.
    Biosci Rep; 2021 Dec 22; 41(12):. PubMed ID: 34821362
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X, Han X, Wei P, Yang J, Sun J.
    Cancer Biol Ther; 2020 May 03; 21(5):452-462. PubMed ID: 32089062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.